Contact Supplier

Contact Supplier

To get in touch with ARTES Biotechnology GmbH, simply fill out the form below.

    Subscribe to Supplier

    Subscribe to Supplier


    ARTES adds direct reagent sales for laboratories

    news-releasesARTES Biotechnology GmbH
    December 7th 2023

    Langenfeld, Germany: –Specialist in microbial process development and technology transfer for the pharmaceutical industry, ARTES Biotechnology GmbH (ARTES), has added a new business stream, selling high quality functional reagents direct to research laboratories.

    The new ‘made with ARTES’ research product catalog encompasses a broad range of authentic animal-free antigen serotypes, enzymes and functional research grade protein free of peptide-tags and modifications.

    Leveraging ARTES technology

    ARTES Business Development Director Dr. Melanie Piontek commented: “We have moved to meet the pharma industry demand for greater material support for research laboratories engaged in diagnostic and vaccine research and biotechnology in general. These teams need reliable, responsive and good value EU-sourced supply of dependable reagents.”

    The ARTES offer provides labs with HBsAG and HPV antigens in the form of non-infective virus-like particles resembling the native virus serotype conformation, along with Endoglycosidase H, Inorganic Pyrophosphatase, and T7 RNA Polymerase recombinant enzymes and the functional protein Brazzein. A further product, Human Serum Albumin, will be added to the line shortly.

    “Our ‘Made with ARTES’ strapline refers to the ways in which we can take advantage of our high-efficiency ARTES technology platform to produce authentic products that are tag- and virus-free, do not incorporate animal components, and that can be offered at attractive prices to the industry and to academic institutions,” Dr. Piontek explained.

    About ARTES Biotechnology

    ARTES Biotechnology GmbH is a Germany-based company specialized in development of recombinant protein production processes from microbial expression systems. The offer is particular in the development of optimized production cell lines and processes based on yeast (Hansenula, Pichia, Saccharomyces) and bacteria (E. coli). The expression platform is complemented by a unique virus-like particle (VLP) technology for antigen presentation and vaccine development.

    For more than 20 years, ARTES partners successfully with human and animal health companies, enzyme manufacturer, the cosmetic, diagnostic and nutrition industry. Operation worldwide takes place from its 870 sqm facilities in Langenfeld.


    Click on Made with ARTES Product Sales for further information.


    ARTES Biotechnology is a globally working, well established and reliable technology provider for recombinant protein production.

    ARTES adds direct reagent sales for laboratories

    Contact ARTES Biotechnology GmbH

    Simply fill out the form below to contact ARTES Biotechnology GmbH now.

    Send ARTES Biotechnology GmbH a Message